14 studies found for:    Alzheimer's | Open Studies | United States, Utah
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
2 Recruiting Efficacy and Safety of MK-7622 as Adjunct Therapy to Donepezil in Participants With Alzheimer's Disease (MK-7622-012)
Condition: Alzheimer's Disease
Interventions: Drug: MK-7622;   Drug: Placebo;   Drug: Donepezil
3 Recruiting An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738)
Condition: Alzheimer's Disease
Interventions: Drug: MK-8931 (Part I and Part II);   Drug: Placebo (Part I);   Drug: MK-8931 (Part II)
4 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
5 Recruiting Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
Condition: Mild Cognitive Impairment Due to Alzheimer's Disease
Interventions: Drug: Pioglitazone;   Drug: Pioglitazone placebo
6 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
7 Recruiting AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Condition: Alzheimer's Disease
Interventions: Drug: AC-1204;   Drug: Placebo
8 Recruiting Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
9 Recruiting A Study of Gantenerumab in Patients With Mild Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Drug: gantenerumab;   Drug: placebo
10 Recruiting A Study of LY3002813 in Participants With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: LY3002813-IV;   Biological: LY3002183-SC;   Drug: Placebo-IV
11 Recruiting Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Condition: Cognition Disorders
Interventions: Drug: Solanezumab;   Drug: Placebo
12 Recruiting Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
13 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo
14 Recruiting Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo

Indicates status has not been verified in more than two years